European Huntington's Disease Network
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Huntington's Disease and Pain
Role: collaborator
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Role: collaborator
REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
Role: lead
REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
Role: lead
An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Role: collaborator
Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Role: collaborator
All 6 trials loaded